95 related articles for article (PubMed ID: 6872621)
1. Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillin.
Choi C; Bayer AS; Fujita NK; Lam K; Guze LB; Yoshikawa TT
Chemotherapy; 1983; 29(4):303-12. PubMed ID: 6872621
[TBL] [Abstract][Full Text] [Related]
2. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
Bayer AS; Kim KS
Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
Bayer AS; Norman D; Kim KS
Antimicrob Agents Chemother; 1985 Dec; 28(6):781-5. PubMed ID: 3909954
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Johnson DE; Thompson B
Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
Shyu WC; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
[TBL] [Abstract][Full Text] [Related]
7. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
[TBL] [Abstract][Full Text] [Related]
8. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
Bayer AS; Hirano L; Yih J
Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
Pefanis A; Giamarellou H; Karayiannakos P; Donta I
Antimicrob Agents Chemother; 1993 Feb; 37(2):308-13. PubMed ID: 8452362
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
Papadakis JA; Samonis G; Maraki S; Boutsikakis J; Petrocheilou V; Saroglou G
Chemotherapy; 2000; 46(2):116-21. PubMed ID: 10671762
[TBL] [Abstract][Full Text] [Related]
11. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.
Levison ME; Kobasa WD
Antimicrob Agents Chemother; 1984 Jun; 25(6):683-6. PubMed ID: 6742813
[TBL] [Abstract][Full Text] [Related]
12. Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.
Bouvet A; Cremieux AC; Contrepois A; Vallois JM; Lamesch C; Carbon C
Antimicrob Agents Chemother; 1985 Nov; 28(5):607-11. PubMed ID: 4091526
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
Faden HS; Deshpande GN; Grossi M; Surgalla M; Ettinger LJ; Freeman AI
Med Pediatr Oncol; 1981; 9(5):501-9. PubMed ID: 7300805
[TBL] [Abstract][Full Text] [Related]
14. Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
Verghese A; Berk SL
Am J Med; 1983 Jun; 74(6):1092. PubMed ID: 6222648
[No Abstract] [Full Text] [Related]
15. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Peterson LR; Gerding DN; Moody JA; Fasching CE
Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
Xiong YQ; Kupferwasser LI; Zack PM; Bayer AS
Antimicrob Agents Chemother; 1999 Jul; 43(7):1737-42. PubMed ID: 10390232
[TBL] [Abstract][Full Text] [Related]
17. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.
Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL
Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
Love LJ; Schimpff SC; Hahn DM; Young VM; Standiford HC; Bender JF; Fortner CL; Wiernik PH
Am J Med; 1979 Apr; 66(4):603-10. PubMed ID: 373439
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
Bayer AS; Blomquist IK; Kim KS
J Antimicrob Chemother; 1986 May; 17(5):641-9. PubMed ID: 2941403
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
Klastersky J; Glauser MP; Schimpff SC; Zinner SH; Gaya H
Antimicrob Agents Chemother; 1986 Feb; 29(2):263-70. PubMed ID: 3521475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
